Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Groen

Showing results (371-380 of 456) with videos related to

Pageof 46
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 17, 1998
Feasibility of tumor imaging using L-3-[iodine-123]-iodo-alpha-methyl-tyrosine in extracranial tumorsP L Jager, E J Franssen, W Kool, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 5, 2022
Multidisciplinary management of chronic refractory pain in autosomal dominant polycystic kidney diseaseFranka van Luijk, Ron T Gansevoort, Hans Blokzijl, et al.
Veterinary Microbiology|June 1, 1990
Mass mortality in seals caused by a newly discovered morbillivirusA D Osterhaus, J Groen, H E Spijkers, et al.
British Journal of Cancer|January 1, 1997
Randomized comparison of etoposide pharmacokinetics after oral etoposide phosphate and oral etoposideR S de Jong, N H Mulder, D R Uges, et al.
European Journal of Cancer (Oxford, England : 1990)|February 21, 1998
Role of recombinant interferon-gamma maintenance in responding patients with small cell lung cancer. A randomised phase III study of the EORTC Lung Cancer Cooperative GroupN van Zandwijk, H J Groen, P E Postmus, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 3, 2000
Treatment of brain metastases of small-cell lung cancer: comparing teniposide and teniposide with whole-brain radiotherapy--a phase III study of the European Organization for the Research and Treatment of Cancer Lung Cancer Cooperative GroupP E Postmus, H Haaxma-Reiche, E F Smit, et al.
European Journal of Cancer (Oxford, England : 1990)|February 1, 1996
Activity of gemcitabine in patients with non-small cell lung cancer: a multicentre, extended phase II studyU Gatzemeier, F A Shepherd, T Le Chevalier, et al.
Vector Borne and Zoonotic Diseases (Larchmont, N.Y.)|August 27, 2011
Molecular diagnostics of Rickettsia africae infection in travelers returning from South Africa to The NetherlandsRosanne W Wieten, Joppe W R Hovius, Emilie J Groen, et al.
British Journal of Cancer|March 10, 1999
Phase I and pharmacokinetic study of the topoisomerase II catalytic inhibitor fostriecinR S de Jong, N H Mulder, D R Uges, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 2002
Phase I and pharmacologic study of liposomal lurtotecan, NX 211: urinary excretion predicts hematologic toxicityDiederik F S Kehrer, Annelies M Bos, Jaap Verweij, et al.
Pageof 46

Showing results (371-380 of 456) with videos related to

Sort By:
Pageof 46
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 17, 1998
Feasibility of tumor imaging using L-3-[iodine-123]-iodo-alpha-methyl-tyrosine in extracranial tumorsP L Jager, E J Franssen, W Kool, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 5, 2022
Multidisciplinary management of chronic refractory pain in autosomal dominant polycystic kidney diseaseFranka van Luijk, Ron T Gansevoort, Hans Blokzijl, et al.
Veterinary Microbiology|June 1, 1990
Mass mortality in seals caused by a newly discovered morbillivirusA D Osterhaus, J Groen, H E Spijkers, et al.
British Journal of Cancer|January 1, 1997
Randomized comparison of etoposide pharmacokinetics after oral etoposide phosphate and oral etoposideR S de Jong, N H Mulder, D R Uges, et al.
European Journal of Cancer (Oxford, England : 1990)|February 21, 1998
Role of recombinant interferon-gamma maintenance in responding patients with small cell lung cancer. A randomised phase III study of the EORTC Lung Cancer Cooperative GroupN van Zandwijk, H J Groen, P E Postmus, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 3, 2000
Treatment of brain metastases of small-cell lung cancer: comparing teniposide and teniposide with whole-brain radiotherapy--a phase III study of the European Organization for the Research and Treatment of Cancer Lung Cancer Cooperative GroupP E Postmus, H Haaxma-Reiche, E F Smit, et al.
European Journal of Cancer (Oxford, England : 1990)|February 1, 1996
Activity of gemcitabine in patients with non-small cell lung cancer: a multicentre, extended phase II studyU Gatzemeier, F A Shepherd, T Le Chevalier, et al.
Vector Borne and Zoonotic Diseases (Larchmont, N.Y.)|August 27, 2011
Molecular diagnostics of Rickettsia africae infection in travelers returning from South Africa to The NetherlandsRosanne W Wieten, Joppe W R Hovius, Emilie J Groen, et al.
British Journal of Cancer|March 10, 1999
Phase I and pharmacokinetic study of the topoisomerase II catalytic inhibitor fostriecinR S de Jong, N H Mulder, D R Uges, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 2002
Phase I and pharmacologic study of liposomal lurtotecan, NX 211: urinary excretion predicts hematologic toxicityDiederik F S Kehrer, Annelies M Bos, Jaap Verweij, et al.
Pageof 46